Vertex Pharmaceuticals
VRTX
#142
Rank
NZ$201.12 B
Marketcap
$780.99
Share price
-1.33%
Change (1 day)
38.28%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): NZ$0.38 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$10.62 Billion. In 2023 the company made an earning of NZ$7.51 Billion, an increase over its 2022 earnings that were of NZ$7.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.38 B-94.93%
2023 NZ$7.51 B3.19%
2022 NZ$7.28 B53.56%
2021 NZ$4.74 B-12.06%
2020 NZ$5.39 B118.45%
2019 NZ$2.47 B120.64%
2018 NZ$1.11 B1473.64%
2017 NZ$71.14 M197.6%
2016 NZ$23.9 M-102.97%
2015 -NZ$0.81 Billion-28.46%
2014 -NZ$1.13 Billion-51.5%
2013 -NZ$2.32 Billion-30584.68%
2012 NZ$7.61 M-95.47%
2011 NZ$0.16 B
2009 -NZ$1.01 Billion
2007 -NZ$0.71 Billion83.1%
2006 -NZ$0.39 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.38 Billion
2000 -NZ$64.66 Million-20.38%
1999 -NZ$81.2 Million31.62%
1998 -NZ$61.7 Million91.05%
1997 -NZ$32.3 Million-36.24%
1996 -NZ$50.65 Million12.45%
1995 -NZ$45.04 Million27.4%
1994 -NZ$35.35 Million-1833.33%
1993 NZ$2.03 M-112.12%
1992 -NZ$16.83 Million175%
1991 -NZ$6.12 Million-12.2%
1990 -NZ$6.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$0.29 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.23 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$25.44 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$11.7 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.26 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.19 Billion-135.77%๐Ÿ‡บ๐Ÿ‡ธ USA